Composition for treating chicken escherichia coli infection and preparation method thereof

Abstract

The invention discloses a composition for treating chicken escherichia coli infection and a preparation method thereof, and aims to provide a composition for treating chicken escherichia coli infection and treating the root cause and symptoms of disease and a preparation method. The composition comprises the following components in percentage by weight: 5 to 15 percent of amoxicillin, 3 to 10 percent of ofloxacin, 3 to 10 percent of taurine, 5 percent of anhydrous sodium carbonate and the balance of anhydrous dextrose. The amoxicillin and the ofloxacin adopted in the composition can effectively kill escherichia coli aiming at etiology; the combination of the amoxicillin and the ofloxacin can reduce the probability of medicament resistance of the escherichia coli and improve the sensitivity, and also has good effect on other bacterial diseases secondarily infected by the escherichia coli; the taurine with anti-inflammatory effect has the effect of quickly diminishing inflammation caused by the escherichia coli; and the anhydrous sodium carbonate is used as a co-solvent so that the composition can be fully dissolved in water and is convenient to use. The medicaments are used together so that the composition can effectively resist etiology and clinical symptoms and treat both principal and secondary aspects of diseases aiming at the etiology and the diseases.

Description

technical field [0001] The invention relates to a composition for treating chicken Escherichia coli infection and a preparation method thereof. Background technique [0002] Chicken Escherichia coli infection is a common disease in chickens in recent years. The pathogen is Escherichia coli, etc. The main clinical manifestations are sepsis, pericarditis, perihepatitis, air sac inflammation, salpingitis, peritonitis, E. coli granuloma, enteritis and other symptoms. Can seriously cause systemic infection, cause resistance drop and cause multiple diseases. [0003] The main difficulties in the treatment of this disease are serious drug resistance of Escherichia coli, severe inflammatory response, and widespread secondary infection. In addition, Escherichia coli itself is a resident bacterium in the body. In the event of a disease, the user often simply treats poorly in terms of drug selection and medication, and the delay in treatment due to the emergence of drug resistance and...

AI Technical Summary

Problems solved by technology

[0003] The main difficulties in the treatment of this disease are serious drug resistance of Escherichia coli, severe inflammatory response, and widespread secondary infection. In addition, Escherichia coli itself is a resident bacterium in the body. In the event of a disease, users often have poor results in simple treatment in terms of drug selection and medication. Due to the emergence of drug resistance, the timing of treatment is delayed and the inflammation cannot be eliminated in time, resulting in a large number of deaths and huge economic losses.